# Oskar Hansson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/oskar-hansson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 89,426 |
| Field | Alzheimer's disease research and treatments |
| h-index | 148 |
| i10-index | 711 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5049277633 |
| ORCID iD | https://orcid.org/0000-0001-8467-7286 |
| Works | 1,626 |

## Researcher papers

Showing 12 of 17.

- [Donanemab in Early Symptomatic Alzheimer Disease](https://scholariq.org/papers/donanemab-in-early-symptomatic-alzheimer-disease/)
- [Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup](https://scholariq.org/papers/revised-criteria-for-diagnosis-and-staging-of-alzheimer-s-disease-alzheimer-s/)
- [Brain charts for the human lifespan](https://scholariq.org/papers/brain-charts-for-the-human-lifespan/)
- [Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders](https://scholariq.org/papers/discriminative-accuracy-of-plasma-phospho-tau217-for-alzheimer-disease-vs-other/)
- [Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology](https://scholariq.org/papers/diagnostic-value-of-cerebrospinal-fluid-neurofilament-light-protein-in-neurology/)
- [Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers](https://scholariq.org/papers/strategic-roadmap-for-an-early-diagnosis-of-alzheimer-s-disease-based-on/)
- [Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study](https://scholariq.org/papers/plasma-phosphorylated-tau-217-and-phosphorylated-tau-181-as-biomarkers-in/)
- [Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease](https://scholariq.org/papers/spread-of-pathological-tau-proteins-through-communicating-neurons-in-human/)
- [Discriminative Accuracy of \[<sup>18</sup>F\]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders](https://scholariq.org/papers/discriminative-accuracy-of-sup-18-sup-f-flortaucipir-positron-emission/)
- [Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease](https://scholariq.org/papers/detailed-comparison-of-amyloid-pet-and-csf-biomarkers-for-identifying-early/)
- [Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease](https://scholariq.org/papers/functional-brain-architecture-is-associated-with-the-rate-of-tau-accumulation-in/)
- [Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum](https://scholariq.org/papers/prevalence-estimates-of-amyloid-abnormality-across-the-alzheimer-disease/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Advanced Neuroimaging Techniques and Applications](https://scholariq.org/topics/advanced-neuroimaging-techniques-and-applications/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.